Madrigal Pharma Adds Another Genetic Medicine to Its Drug Combo Strategy in MASHNews DeskMay 5, 20260 Madrigal Pharmaceuticals, maker of the first FDA-approved medicine for the fatty liver disease MASH, has been exploring combinations of that…
Startup Nula Emerges to Advance a New Class Medicines for Metabolic DiseaseNews DeskApril 16, 20260 In a cell, the nucleus and related genetic material are housed inside a double-layered membrane. Scientists previously thought this nuclear…